Skip to content

Adherence to Treatment in Hemophilia

Psychosocial Factors and Adherence to Treatment in Patients With Hemophilia. A Multicenter Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02191436
Acronym
ADHERENCE
Enrollment
200
Registered
2014-07-16
Start date
2015-05-31
Completion date
2016-02-29
Last updated
2015-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemophilia

Keywords

Haemophilia, Adherence, Family Functioning, Quality of Life, Anxiety, Illness Behavior, Coping Strategies

Brief summary

Psychosocial factors and adherence to treatment in patients with hemophilia. A multicenter study. Multicenter cross sectional study of patients with hemophilia and their families

Detailed description

Research project whose main objective is to assess adherence and major psychosocial issues affecting patients with hemophilia and their families treated at the Hematology and hemotherapy Services Clinical Hospital Universitario Virgen de la Arrixaca of Murcia and the University Hospital Carlos Haya, Malaga. The data obtained in this project will identify those psychosocial aspects affecting patients and their families about the disease, its evolution and treatment of it. They will use different psychosocial questionnaires based on scientific evidence and the reliability of these, as well as its specific design for hemophilia patients. The main characteristics of the study are: * Descriptive study of adherence to treatment of pediatric patients, adolescents and adults with hemophilia. * Descriptive study of family functioning, perceived stress, anxiety and quality of life in parents of children with hemophilia under 14 years and adolescents with hemophilia, depending on the administered medical treatment, clinical and musculoskeletal patient situation. * Descriptive study of illness behavior or perception of illness, perceived stress, anxiety, quality of life and coping strategies of young adults with hemophilia, depending on the medical treatment administered, and skeletal muscle clinical situation of the patient. * Validation of psychosocial assessment tools in patients with hemophilia and their families.

Interventions

None listed

Sponsors

Pfizer
CollaboratorINDUSTRY
ANA TORRES-ORTUÑO
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
6 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with hemophilia A or B * Patients followed at the Hematology Department of the hospitals included in the study * Patients without cognitive disorders

Exclusion criteria

* Patients with other congenital coaguopatías * Patients with more than 2 years without going to review your hospital * Patients from other provinces of Spain

Design outcomes

Primary

MeasureTime frameDescription
Assess adherence to treatment of patients with hemophilia.Screening visitTo assess this variable we use the Beliefs About Medication Questionnaire (BMQ).
Assess the perceived stress of parents of children with hemophilia.Screening visitTo assess this variable we use the Pediatric Inventory for Parents (PIP).
Assessing the personality traits of children with hemophilia.Screening visitTo assess this variable we use the Eysenck Personality Questionnaire Junior (EPQ-J)
Assess the perception of quality of lifeScreening visitThe quality of life assessed with the questionnaires: Short Form-36 Health Survey (SF-36) and A36 Hemofilia-QoL for adults; and Child Report Form (CHIP-CE) and Haemo-QoL, for children.
Assess the perception of illness of the patientsScreening visitTo measure this variable we use the Illness Perception Questionnaire Revised (IPQ-R).
Assess anxiety of patients and parents of children with hemophilia.Screening visitTo evaluate this variable we use the State-Trait Anxiety Inventory (STAI)
To assess illness behavior of patients.Screening visitTo assess this variable we use the illness behaviour questionnaire (IBQ).
Assessing coping strategies of patients.Screening visitTo assess this variable we use the Coping Scale questionnaire.
Assess the perception of family functioning of parents of children with hemophiliaScreening visitTo assess this variable we use the Family Functioning Evaluation Scale (FACES III).

Secondary

MeasureTime frameDescription
Assess the demographic data of the patientScreening visitAge, history of hemophilia in the family, marital status (single, married, divorced), education (university, basic), employment status (unemployed, self-employed, employed by others), distance to hospital
Assess the clinical data of the patientScreening visitType of hemophilia (A or B), severity of hemophilia (severe, moderate or mild), treatment type (a demand or prophylaxis), presence of ingibidores, history of hemarthrosis, dosage factor VIII / IX

Countries

Spain

Contacts

Primary ContactANA TORRES-ORTUÑO, PhD
atorres.ortuno@gmail.com868887170
Backup ContactRUBÉN CUESTA-BARRIUSO, PhD
ruben.cuestab@gmail.com968278806

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026